S&P 500   4,549.05 (-0.13%)
DOW   35,423.88 (+0.02%)
QQQ   389.76 (-0.11%)
AAPL   189.20 (-0.63%)
MSFT   379.04 (-0.96%)
META   332.48 (-1.92%)
GOOGL   135.05 (-1.57%)
AMZN   146.22 (-0.55%)
TSLA   243.97 (-1.11%)
NVDA   482.05 (+0.80%)
NIO   7.16 (-0.69%)
BABA   74.75 (-2.59%)
AMD   123.61 (+1.31%)
T   16.29 (+0.68%)
F   10.60 (+2.22%)
MU   76.55 (+0.56%)
CGC   0.56 (+3.87%)
GE   118.84 (+-0.01%)
DIS   92.45 (-0.05%)
AMC   7.15 (+6.72%)
PFE   30.03 (+1.15%)
PYPL   57.93 (-0.92%)
XOM   102.08 (-1.75%)
S&P 500   4,549.05 (-0.13%)
DOW   35,423.88 (+0.02%)
QQQ   389.76 (-0.11%)
AAPL   189.20 (-0.63%)
MSFT   379.04 (-0.96%)
META   332.48 (-1.92%)
GOOGL   135.05 (-1.57%)
AMZN   146.22 (-0.55%)
TSLA   243.97 (-1.11%)
NVDA   482.05 (+0.80%)
NIO   7.16 (-0.69%)
BABA   74.75 (-2.59%)
AMD   123.61 (+1.31%)
T   16.29 (+0.68%)
F   10.60 (+2.22%)
MU   76.55 (+0.56%)
CGC   0.56 (+3.87%)
GE   118.84 (+-0.01%)
DIS   92.45 (-0.05%)
AMC   7.15 (+6.72%)
PFE   30.03 (+1.15%)
PYPL   57.93 (-0.92%)
XOM   102.08 (-1.75%)
S&P 500   4,549.05 (-0.13%)
DOW   35,423.88 (+0.02%)
QQQ   389.76 (-0.11%)
AAPL   189.20 (-0.63%)
MSFT   379.04 (-0.96%)
META   332.48 (-1.92%)
GOOGL   135.05 (-1.57%)
AMZN   146.22 (-0.55%)
TSLA   243.97 (-1.11%)
NVDA   482.05 (+0.80%)
NIO   7.16 (-0.69%)
BABA   74.75 (-2.59%)
AMD   123.61 (+1.31%)
T   16.29 (+0.68%)
F   10.60 (+2.22%)
MU   76.55 (+0.56%)
CGC   0.56 (+3.87%)
GE   118.84 (+-0.01%)
DIS   92.45 (-0.05%)
AMC   7.15 (+6.72%)
PFE   30.03 (+1.15%)
PYPL   57.93 (-0.92%)
XOM   102.08 (-1.75%)
S&P 500   4,549.05 (-0.13%)
DOW   35,423.88 (+0.02%)
QQQ   389.76 (-0.11%)
AAPL   189.20 (-0.63%)
MSFT   379.04 (-0.96%)
META   332.48 (-1.92%)
GOOGL   135.05 (-1.57%)
AMZN   146.22 (-0.55%)
TSLA   243.97 (-1.11%)
NVDA   482.05 (+0.80%)
NIO   7.16 (-0.69%)
BABA   74.75 (-2.59%)
AMD   123.61 (+1.31%)
T   16.29 (+0.68%)
F   10.60 (+2.22%)
MU   76.55 (+0.56%)
CGC   0.56 (+3.87%)
GE   118.84 (+-0.01%)
DIS   92.45 (-0.05%)
AMC   7.15 (+6.72%)
PFE   30.03 (+1.15%)
PYPL   57.93 (-0.92%)
XOM   102.08 (-1.75%)

Helmerich & Payne Stock Price, News & Analysis (NYSE:HP)

$36.44
+0.07 (+0.19%)
(As of 03:51 PM ET)
Compare
Today's Range
$36.11
$36.93
50-Day Range
$36.93
$44.73
52-Week Range
$30.41
$52.65
Volume
1.02 million shs
Average Volume
1.40 million shs
Market Capitalization
$3.62 billion
P/E Ratio
8.76
Dividend Yield
2.74%
Price Target
$42.38

Helmerich & Payne MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
15.4% Upside
$42.38 Price Target
Short Interest
Bearish
7.08% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-8.40
Upright™ Environmental Score
News Sentiment
-0.20mentions of Helmerich & Payne in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$1.46 M Sold Last Quarter
Proj. Earnings Growth
14.71%
From $3.06 to $3.51 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Oils/Energy Sector

170th out of 233 stocks

Drilling Oil & Gas Wells Industry

9th out of 12 stocks


HP stock logo

About Helmerich & Payne Stock (NYSE:HP)

Founded in 1920, Helmerich & Payne, Inc. (H&P) (NYSE: HP) is committed to delivering industry leading levels of drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for its customers and returns for shareholders. Through its subsidiaries, the Company designs, fabricates and operates high-performance drilling rigs in conventional and unconventional plays around the world. H&P also develops and implements advanced automation, directional drilling and survey management technologies. H&P’s fleet includes 299 land rigs in the U.S., 31 international land rigs and eight offshore platform rigs.

HP Stock Price History

HP Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Helmerich & Payne (NYSE:HP) Downgraded to Hold at StockNews.com
StockNews.com Lowers Helmerich & Payne (NYSE:HP) to Hold
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Helmerich & Payne: 2 Bright Spots Amidst Market Tumult
3 Compelling Energy Stocks Investors Are Buying
Helmerich & Payne Stock Sees Composite Rating Jump To 96
3 Best Stocks to Consider in the Energy Sector
Helmerich & Payne (HP) Receives a Rating Update from a Top Analyst
See More Headlines
Receive HP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helmerich & Payne and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 8/31 Dividend
8/16/2023
Dividend Payable
8/31/2023
Last Earnings
11/09/2023
Ex-Dividend for 12/4 Dividend
11/17/2023
Today
11/29/2023
Dividend Payable
12/04/2023
Next Earnings (Estimated)
1/29/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Drilling oil & gas wells
Sub-Industry
Oil & Gas Drilling
CUSIP
42345210
Employees
6,200
Year Founded
1920

Price Target and Rating

Average Stock Price Target
$42.38
High Stock Price Target
$47.00
Low Stock Price Target
$37.00
Potential Upside/Downside
+16.5%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
10 Analysts

Profitability

Net Income
$434.10 million
Pretax Margin
20.66%

Debt

Sales & Book Value

Annual Sales
$2.87 billion
Cash Flow
$7.96 per share
Book Value
$27.88 per share

Miscellaneous

Free Float
95,291,000
Market Cap
$3.62 billion
Optionable
Optionable
Beta
1.69

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report














HP Stock Analysis - Frequently Asked Questions

Should I buy or sell Helmerich & Payne stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Helmerich & Payne in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HP, but not buy additional shares or sell existing shares.
View HP analyst ratings
or view top-rated stocks.

What is Helmerich & Payne's stock price target for 2024?

10 brokers have issued 1 year price objectives for Helmerich & Payne's shares. Their HP share price targets range from $37.00 to $47.00. On average, they predict the company's share price to reach $42.38 in the next twelve months. This suggests a possible upside of 16.5% from the stock's current price.
View analysts price targets for HP
or view top-rated stocks among Wall Street analysts.

How have HP shares performed in 2023?

Helmerich & Payne's stock was trading at $49.57 at the beginning of the year. Since then, HP shares have decreased by 26.6% and is now trading at $36.37.
View the best growth stocks for 2023 here
.

Are investors shorting Helmerich & Payne?

Helmerich & Payne saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 6,750,000 shares, an increase of 19.9% from the October 31st total of 5,630,000 shares. Based on an average trading volume of 1,270,000 shares, the days-to-cover ratio is presently 5.3 days. Currently, 7.1% of the company's stock are sold short.
View Helmerich & Payne's Short Interest
.

When is Helmerich & Payne's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, January 29th 2024.
View our HP earnings forecast
.

How were Helmerich & Payne's earnings last quarter?

Helmerich & Payne, Inc. (NYSE:HP) released its earnings results on Thursday, November, 9th. The oil and gas company reported $0.69 earnings per share for the quarter, missing analysts' consensus estimates of $0.72 by $0.03. The oil and gas company earned $659.61 million during the quarter, compared to analysts' expectations of $662.17 million. Helmerich & Payne had a trailing twelve-month return on equity of 15.76% and a net margin of 15.11%. The firm's revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.45 earnings per share.

How often does Helmerich & Payne pay dividends? What is the dividend yield for Helmerich & Payne?

Helmerich & Payne announced a quarterly dividend on Tuesday, October 17th. Stockholders of record on Monday, November 20th will be given a dividend of $0.25 per share on Monday, December 4th. This represents a $1.00 dividend on an annualized basis and a yield of 2.75%. The ex-dividend date is Friday, November 17th.
Read our dividend analysis for HP
.

Is Helmerich & Payne a good dividend stock?

Helmerich & Payne (NYSE:HP) pays an annual dividend of $1.00 per share and currently has a dividend yield of 2.71%. The dividend payout ratio is 24.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HP will have a dividend payout ratio of 28.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HP.

What is John Lindsay's approval rating as Helmerich & Payne's CEO?

97 employees have rated Helmerich & Payne Chief Executive Officer John Lindsay on Glassdoor.com. John Lindsay has an approval rating of 92% among the company's employees. This puts John Lindsay in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Helmerich & Payne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helmerich & Payne investors own include AT&T (T), CA (CA), Exxon Mobil (XOM), Johnson & Johnson (JNJ), Pfizer (PFE), Verizon Communications (VZ), Boeing (BA), Intel (INTC), Cisco Systems (CSCO) and Gilead Sciences (GILD).

Who are Helmerich & Payne's major shareholders?

Helmerich & Payne's stock is owned by many different retail and institutional investors. Top institutional investors include Earnest Partners LLC (2.95%), Victory Capital Management Inc. (2.43%), Boston Trust Walden Corp (2.19%), Invesco Ltd. (1.98%), Van ECK Associates Corp (1.92%) and Northern Trust Corp (1.79%). Insiders that own company stock include Hans Helmerich, John R Bell, John W Lindsay, Michael Lennox, Raymond John Adams III, Sara Marie Momper and Todd Willard Benson.
View institutional ownership trends
.

How do I buy shares of Helmerich & Payne?

Shares of HP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:HP) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -